Paper31938457
Fluorescence Labeling of Neurotensin(8-13) via Arginine Residues Gives Molecular Tools with High Receptor Affinity.
Keller M and 10 others. ACS Med Chem Lett, 2020. Cited by 24 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Fluorescence Labeling of Neurotensin(8-13) via Arginine Residues Gives Molecular Tools with High Receptor Affinity. Papers, record 31938457. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/31938457
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Fluorescence Labeling of Neurotensin(8-13) via Arginine Residues Gives Molecular Tools with High Receptor Affinity.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References34
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28,970,469 | Extrapyramidal side effects of antipsychotics are linked to their association kinetics at dopamine D2 receptors. | Nat Commun | 2017 | https://conductscience.org/library/papers/28970469 | PubMed |
| 2 | 18,781,940 | Fluorescent GPCR ligands as new tools in pharmacology. | Curr Med Chem | 2008 | https://conductscience.org/library/papers/18781940 | PubMed |
| 3 | 9,616,318 | Neurotensin receptors: a new marker for human ductal pancreatic adenocarcinoma. | Gut | 1998 | https://conductscience.org/library/papers/9616318 | PubMed |
| 4 | 4,745,447 | The isolation of a new hypotensive peptide, neurotensin, from bovine hypothalami. | J Biol Chem | 1973 | https://conductscience.org/library/papers/4745447 | PubMed |
| 5 | 16,125,436 | Fluorophore-tagged GPCR ligands. | Curr Opin Chem Biol | 2005 | https://conductscience.org/library/papers/16125436 | PubMed |
| 6 | 25,010,291 | Portraying G protein-coupled receptors with fluorescent ligands. | ACS Chem Biol | 2014 | https://conductscience.org/library/papers/25010291 | PubMed |
| 7 | 8,189,037 | Synthesis of a biologically active fluorescent probe for labeling neurotensin receptors. | J Histochem Cytochem | 1994 | https://conductscience.org/library/papers/8189037 | PubMed |
| 8 | 15,468,079 | Chameleon labels for staining and quantifying proteins. | Angew Chem Int Ed Engl | 2004 | https://conductscience.org/library/papers/15468079 | PubMed |
| 9 | 16,901,585 | Internalization and recycling properties of neurotensin receptors. | Peptides | 2006 | https://conductscience.org/library/papers/16901585 | PubMed |
| 10 | 10,803,605 | High throughput fluorescence polarization: a homogeneous alternative to radioligand binding for cell surface receptors. | J Biomol Screen | 2000 | https://conductscience.org/library/papers/10803605 | PubMed |
| 11 | 1,167,549 | The amino acid sequence of a hypothalamic peptide, neurotensin. | J Biol Chem | 1975 | https://conductscience.org/library/papers/1167549 | PubMed |
| 12 | 21,446,649 | Discovery of highly potent and neurotensin receptor 2 selective neurotensin mimetics. | J Med Chem | 2011 | https://conductscience.org/library/papers/21446649 | PubMed |
| 13 | 8,381,365 | Cloning and expression of a complementary DNA encoding a high affinity human neurotensin receptor. | FEBS Lett | 1993 | https://conductscience.org/library/papers/8381365 | PubMed |
| 14 | 10,390,649 | Neurotensin and neurotensin receptors. | Trends Pharmacol Sci | 1999 | https://conductscience.org/library/papers/10390649 | PubMed |
| 15 | 25,189,338 | Targeting neuropeptide receptors for cancer imaging and therapy: perspectives with bombesin, neurotensin, and neuropeptide-Y receptors. | J Nucl Med | 2014 | https://conductscience.org/library/papers/25189338 | PubMed |
| 16 | 25,174,921 | Fluorescent GPCR ligands as new tools in pharmacology-update, years 2008-early 2014. | Curr Med Chem | 2014 | https://conductscience.org/library/papers/25174921 | PubMed |
| 17 | 26,317,175 | Fluorescence- and bioluminescence-based approaches to study GPCR ligand binding. | Br J Pharmacol | 2016 | https://conductscience.org/library/papers/26317175 | PubMed |
| 18 | 26,954,998 | Homogeneous time-resolved G protein-coupled receptor-ligand binding assay based on fluorescence cross-correlation spectroscopy. | Anal Biochem | 2016 | https://conductscience.org/library/papers/26954998 | PubMed |
| 19 | 7,084,220 | Synthesis and characterization of neurotensin analogues for structure/activity relationship studies. Acetyl-neurotensin-(8--13) is the shortest analogue with full binding and pharmacological activities. | Eur J Biochem | 1982 | https://conductscience.org/library/papers/7084220 | PubMed |
| 20 | 10,934,036 | Ligand-induced internalization of neurotensin in transfected COS-7 cells: differential intracellular trafficking of ligand and receptor. | J Cell Sci | 2000 | https://conductscience.org/library/papers/10934036 | PubMed |
Cited by13
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 24 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,109,681 | Advances in neurotensin receptor 1-targeted molecular probes for tumor molecular imaging and therapy. | Front Oncol | 2026 | https://conductscience.org/library/papers/42109681 | PubMed |
| 40,899,861 | High-Affinity and Proteolytically Stable Peptidic Fluorescent NTS1R Ligands. | J Med Chem | 2025 | https://conductscience.org/library/papers/40899861 | PubMed |
| 40,574,013 | 99mTc-Labeled Diarylpyrazoles for Single-Emission Computer Tomography Imaging of Neurotensin Receptor-Positive Tumors: A Comparative Preclinical Study. | Pharmaceutics | 2025 | https://conductscience.org/library/papers/40574013 | PubMed |
| 39,261,089 | Dually Labeled Neurotensin NTS1R Ligands for Probing Radiochemical and Fluorescence-Based Binding Assays. | J Med Chem | 2024 | https://conductscience.org/library/papers/39261089 | PubMed |
| 39,162,616 | Genetic code expansion, click chemistry, and light-activated PI3K reveal details of membrane protein trafficking downstream of receptor tyrosine kinases. | Elife | 2024 | https://conductscience.org/library/papers/39162616 | PubMed |
| 38,633,582 | Illuminating Neuropeptide Y Y4 Receptor Binding: Fluorescent Cyclic Peptides with Subnanomolar Binding Affinity as Novel Molecular Tools. | ACS Pharmacol Transl Sci | 2024 | https://conductscience.org/library/papers/38633582 | PubMed |
| 37,649,440 | A Biomimetic C-Terminal Extension Strategy for Photocaging Amidated Neuropeptides. | J Am Chem Soc | 2023 | https://conductscience.org/library/papers/37649440 | PubMed |
| 36,805,869 | Theranostic cobalt-55/58m for neurotensin receptor-mediated radiotherapy in vivo: A pilot study with dosimetry. | Nucl Med Biol | 2023 | https://conductscience.org/library/papers/36805869 | PubMed |
| 36,407,949 | Insertion of Nanoluc into the Extracellular Loops as a Complementary Method To Establish BRET-Based Binding Assays for GPCRs. | ACS Pharmacol Transl Sci | 2022 | https://conductscience.org/library/papers/36407949 | PubMed |
| 36,230,845 | Development of a Neurotensin-Derived 68Ga-Labeled PET Ligand with High In Vivo Stability for Imaging of NTS1 Receptor-Expressing Tumors. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/36230845 | PubMed |
| 36,056,076 | Neurotensin analogs by fluoroglycosylation at Nω-carbamoylated arginines for PET imaging of NTS1-positive tumors. | Sci Rep | 2022 | https://conductscience.org/library/papers/36056076 | PubMed |
| 34,665,963 | Screening and Quantification of the Encapsulation of Dyes in Supramolecular Particles. | Langmuir | 2021 | https://conductscience.org/library/papers/34665963 | PubMed |
| 32,832,018 | Fluorescent H2 Receptor Squaramide-Type Antagonists: Synthesis, Characterization, and Applications. | ACS Med Chem Lett | 2020 | https://conductscience.org/library/papers/32832018 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/31938457
GET https://conductscience.org/api/papers/v1/31938457/references?page=2